Stable lipid-comprising drug delivery complexes and methods for their production
    3.
    发明授权
    Stable lipid-comprising drug delivery complexes and methods for their production 失效
    稳定的含脂质药物递送复合物及其生产方法

    公开(公告)号:US08771728B2

    公开(公告)日:2014-07-08

    申请号:US13712804

    申请日:2012-12-12

    IPC分类号: A61K9/127 A61K38/00 C07H21/04

    摘要: Novel stable, concentrated, biologically active and ready-to-use lipid-comprising drug delivery complexes and methods for their production are described. The biological activity of the complexes produced are comparable to the formulations prepared according to the prior art admixture method and upon purification, the complexes produced by the method of this invention are 50 to 500 fold more concentrated than the complexes formed by admixture. The method described herein provides for the large scale production of lipid-comprising drug delivery systems useful for gene therapy and other applications.

    摘要翻译: 描述了新的稳定的,浓缩的,生物活性的和即用型含脂质的药物递送复合物及其生产方法。 所生成的络合物的生物活性与根据现有技术的混合方法制备的制剂相当,并且在纯化后,通过本发明的方法制备的络合物比通过混合物形成的络合物多50至500倍。 本文所述的方法提供大规模生产用于基因治疗和其它应用的含脂质药物递送系统。

    FORMULATIONS AND CARRIER SYSTEMS INCLUDING COMPOUND INTERACTIVE DOMAINS
    7.
    发明申请
    FORMULATIONS AND CARRIER SYSTEMS INCLUDING COMPOUND INTERACTIVE DOMAINS 审中-公开
    制定和载体系统,包括复合交互域

    公开(公告)号:US20150306034A1

    公开(公告)日:2015-10-29

    申请号:US14651840

    申请日:2013-12-12

    摘要: A method of creating a formulation for a compound includes determining a compound interactive agent comprising at least one group that interacts with the compound, creating a carrier agent by conjugating at least one compound interactive domain comprising the at least one group that interacts with the compound with at least one hydrophilic domain, and combining the compound and the carrier agent to create the formulation. Creating the carrier agent may further include conjugating the at least one compound interactive domain with at least one hydrophobic domain so that the at least one compound interactive domain is positioned between the at least one hydrophilic domain and the at least one hydrophobic domain.

    摘要翻译: 创建化合物制剂的方法包括确定包含与化合物相互作用的至少一个基团的化合物相互作用试剂,通过将包含与该化合物相互作用的至少一个基团的至少一个化合物相互作用结构域与 至少一个亲水结构域,并组合化合物和载体试剂以产生制剂。 产生载体试剂可以进一步包括将至少一个化合物交互结构域与至少一个疏水结构域共轭,使得至少一个化合物相互作用结构域位于至少一个亲水结构域和至少一个疏水结构域之间。